Show Summary Details
Page of

Substance Intoxication and Withdrawal States in the General Medical Setting 

Substance Intoxication and Withdrawal States in the General Medical Setting
Chapter:
Substance Intoxication and Withdrawal States in the General Medical Setting
Author(s):

Jody Glance

, Priya Gopalan

, and Kurt D. Ackerman

DOI:
10.1093/med/9780199329311.003.0016
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 September 2020

Substance use disorders (SUDs) are commonly encountered by medical professionals across specialties in the general hospital setting. Failure to recognize intoxication and withdrawal states can lead to improper treatment and unnecessary medical complications. This chapter provides an overview of the clinical approach to identification and management of intoxication and withdrawal states in an acute medical setting. Substances covered include alcohol, benzodiazepines and other GABA-agonists, opioids, cocaine and other stimulants, hallucinogens, and designer drugs including synthetic cannabinoids, synthetic cathinones, and MDMA. Urine drug testing, long-term opioid maintenance treatment, and mixed delirium states are discussed. The necessity to refer patients for further treatment of the SUD is also stressed.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.